Antibody

1,010개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,010 programs
AntibodyLimited DatastaleRochePhase 3

HLX87 + Pertuzumab (HLX87 + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#HER2+BreastCancer+1
Trials 2Status Recruiting
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#monoclonal-antibody#Non-SmallCellLungCancer+1
Trials 2Status Active
AntibodyLimited DatastaleJanssenPhase 1

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#monoclonal-antibody#AcuteLymphoblasticLeukemia+2
Trials 2Status Recruiting
AntibodyLimited DatastaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#monoclonal-antibody#HepatocellularCarcinomaHCC+2
Trials 2Status Recruiting
CGTLimited DatastaleMerckPhase 1

pembrolizumab (Keytruda, Letetresgene autoleucel with pembrolizumab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#Merck
Trials 2Status Discontinued
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 2Status Recruiting
AntibodyLimited DatastaleTakedaPhase 2

Mezagitamab (Mezagitamab)

Relapsed and/or Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#monoclonal-antibody#Relapsedand+2
Trials 2Status Active
AntibodyLimited DatastaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+2
Trials 2Status Recruiting
AntibodyLimited DatastaleRoswell Park Cancer InstitutePhase 1

Nimotuzumab (Nimotuzumab)

EGFR Gene Mutation; Recurrent Non-Small Cell Lung Carcinoma · Advanced Cancer

#AdvancedCancer#Antibody#Phase1#monoclonal-antibody#EGFRGeneMutation+2
Trials 2Status Active
AntibodyLimited DatastaleBeiGenePhase 3

Ociperlimab (Ociperlimab)

Advanced Hepatocellular Carcinoma · FRα

#FR#Antibody#Phase3#monoclonal-antibody#AdvancedHepatocellularCarcinoma+1
Trials 2Status Discontinued
AntibodyLimited DatastaleAbbViePhase 3

adalimumab (Humira, Open-label Adalimumab)

Axial Spondyloarthritis · Axial Spondyloarthritis

#AxialSpondyloarthritis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 2Status Active
AntibodyLimited DatastaleEli LillyPhase 2

Penpulimab combined with cetuximab (Penpulimab combined with cetuximab)

Head and Neck Neoplasms; Recurrent Disease · Head and Neck Neoplasms

#HeadandNeckNeoplasms#Antibody#Phase2#monoclonal-antibody#RecurrentDisease+1
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 2

rituximab (Rituxan, Rituxan (rituximab))

Rheumatoid Arthritis · Lupus Erythematosus, Systemic

#LupusErythematosusSystemic#Antibody#Phase2#monoclonal-antibody#RheumatoidArthritis+1
Trials 2Status Active
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Merck
Trials 2Status Discontinued
AntibodyLimited DatastaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#monoclonal-antibody#AxialSpondylarthritisaxSpA+2
Trials 2Status Active
AntibodyLimited DatastaleMacroGenicsPhase 3

Tebotelimab (Tebotelimab)

Gastric Cancer; Gastroesophageal Junction Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase3#monoclonal-antibody#GastricCancer+2
Trials 2Status Discontinued
AntibodyLimited DatastaleBeiGenePhase 2

atezolizumab (Tecentriq, Tislelizumab/Atezolizumab/ Durvalumab/Benmelstobart/Toripalimab/Serplulimab)

Extensive Stage Lung Small Cell Cancer · Extensive Stage Lung Small Cell Cancer

#ExtensiveStageLungSmallCellCance#Antibody#Phase2#monoclonal-antibody#BeiGene
Trials 2Status Recruiting
AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 1

trastuzumab (Herceptin, US sourced Herceptin®)

Healthy · Healthy

#Healthy#Antibody#Phase1#monoclonal-antibody#Roche
Trials 2Status Active
AntibodyCurated CorestaleRocheApproved

Xolair (Xolair)

Atopic Eczema; Atopic Dermatitis · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 2Status Active

15 / 51 pages

← PreviousNext →